Comment on SARS-CoV-2 genome and spike protein, COVID-19, and efficacy of vaccines

被引：0
|
作者：
Mungmunpuntipantip, Rujittika [1 ]
Wiwanitkit, Viroj [2 ,3 ]
机构：
[1] Private Acad Consultant, Bangkok, Thailand
[2] Chandigarh Univ, Ajitgarh, Punjab, India
[3] Joesph Ayobabalola Univ, Ikeji Arakeji, Nigeria
来源：
CIRUGIA Y CIRUJANOS | 2025年 / 93卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页数：129
相关论文
共 50 条
  • [31] Role of cholesterol in COVID-19 disease and in the SARS-CoV-2 spike interaction
    Kocar, E.
    Skubic, C.
    Ivanusa, P.
    Brzin, J.
    Rezen, T.
    Turel, G.
    Bogovic, P.
    Strle, F.
    Rozman, D.
    FEBS OPEN BIO, 2021, 11 : 504 - 504
  • [32] Phenotypic evolution of SARS-CoV-2 spike during the COVID-19 pandemic
    Furnon, Wilhelm
    Cowton, Vanessa M.
    De Lorenzo, Giuditta
    Orton, Richard
    Herder, Vanessa
    Cantoni, Diego
    Ilia, Georgios
    Mendonca, Diogo Correa
    Kerr, Karen
    Allan, Jay
    Upfold, Nicole
    Meehan, Gavin R.
    Bakshi, Siddharth
    Das, Udeet Ranjan
    Arias, Sergi Molina
    Mcelwee, Marion
    Little, Sarah
    Logan, Nicola
    Kwok, Kirsty
    Smollett, Katherine
    Willett, Brian J.
    Filipe, Ana da Silva
    Robertson, David L.
    Grove, Joe
    Patel, Arvind H.
    Palmarini, Massimo
    NATURE MICROBIOLOGY, 2025, 10 (01): : 77 - 93
  • [33] Neutralising antibody escape of SARS-CoV-2 spike protein: Risk assessment for antibody-based Covid-19 therapeutics and vaccines
    Focosi, Daniele
    Maggi, Fabrizio
    REVIEWS IN MEDICAL VIROLOGY, 2021, 31 (06)
  • [34] SARS-CoV-2 Spike Protein Elicits Cell Signaling in Human Host Cells: Implications for Possible Consequences of COVID-19 Vaccines
    Suzuki, Yuichiro J.
    Gychka, Sergiy G.
    VACCINES, 2021, 9 (01) : 1 - 8
  • [35] Early Outpatient Treatment of SARS-CoV-2 (COVID-19): A Comment
    Korman, Tony M.
    McMahon, James H.
    AMERICAN JOURNAL OF MEDICINE, 2021, 134 (03): : E220 - E221
  • [36] Authors' response: Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: More data on asymptomatic SARS-CoV-2 infection
    Harder, Thomas
    Koch, Judith
    Vygen-Bonnet, Sabine
    Kuelper-Schiek, Wiebe
    Pilic, Antonia
    Reda, Sarah
    Scholz, Stefan
    Wichmann, Ole
    EUROSURVEILLANCE, 2021, 26 (35)
  • [37] Efficacy and safety of four COVID-19 vaccines in preventing SARS-CoV-2 infection: A rapid review
    Moron-Duarte, Lina Sofia
    Chacon, Kelly Rocio
    Gutierrez, Maria Paula
    De la Hoz, Ilich Herbert
    Yomayusa, Nancy
    BIOMEDICA, 2022, 42 : 19 - 31
  • [38] Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients
    Yang Li
    Dan-yun Lai
    Hai-nan Zhang
    He-wei Jiang
    Xiaolong Tian
    Ming-liang Ma
    Huan Qi
    Qing-feng Meng
    Shu-juan Guo
    Yanling Wu
    Wei Wang
    Xiao Yang
    Da-wei Shi
    Jun-biao Dai
    Tianlei Ying
    Jie Zhou
    Sheng-ce Tao
    Cellular & Molecular Immunology, 2020, 17 : 1095 - 1097
  • [39] Inflammation in the COVID-19 airway is due to inhibition of CFTR signaling by the SARS-CoV-2 spike protein
    Caohuy, Hung
    Eidelman, Ofer
    Chen, Tinghua
    Mungunsukh, Ognoon
    Yang, Qingfeng
    Walton, Nathan I.
    Pollard, Bette S.
    Khanal, Sara
    Hentschel, Shannon
    Florez, Catalina
    Herbert, Andrew S.
    Pollard, Harvey B.
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [40] SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines
    Salvatori, Giovanni
    Luberto, Laura
    Maffei, Mariano
    Aurisicchio, Luigi
    Roscilli, Giuseppe
    Palombo, Fabio
    Marra, Emanuele
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
12345